Dobrzyn Agnieszka, Dobrzyn Pawel, Miyazaki Makoto, Sampath Harini, Chu Kiki, Ntambi James M
Department of Biochemistry, University of Wisconsin-Madison, 53706, USA.
J Biol Chem. 2005 Jun 17;280(24):23356-62. doi: 10.1074/jbc.M502436200. Epub 2005 Apr 13.
Stearoyl-CoA desaturase (SCD) is the rate-limiting enzyme in monounsaturated fatty acid synthesis. Previously, we showed that Scd1 deficiency reduces liver triglyceride accumulation and considerably decreases synthesis of very low density lipoprotein and its secretion in both lean and obese mice. In the present study, we found that Scd1 deficiency significantly modulates hepatic glycerophospholipid profile. The content of phosphatidylcholine (PC) was increased by 40% and the activities of CTP:choline cytidylyltransferase (CCT), the rate-limiting enzyme in de novo PC synthesis, and choline phosphotransferase were increased by 64 and 53%, respectively, in liver of Scd1-/- mice. In contrast, the protein level of phosphatidylethanolamine N-methyltransferase, an enzyme involved in PC synthesis via methylation of phosphatidylethanolamine, was decreased by 80% in the liver of Scd1-/- mice. Membrane translocation of CCT is required for its activation. Immunoblot analyses demonstrated that twice as much CCTalpha was associated with plasma membrane in livers of Scd1-/- compared with wild type mice, suggesting that Scd1 mutation leads to an increase in CCT membrane affinity. The incorporation of [(3)H]glycerol into PC was increased by 2.5-fold in Scd1-/- primary hepatocytes compared with those of wild type mice. Furthermore, mitochondrial glycerol-3-phosphate acyltransferase activity was reduced by 42% in liver of Scd1-/- mice; however, the activities of microsomal glycerol-3-phosphate acyltransferase, diacylglycerol acyltransferase, and ethanolamine phosphotransferase were not affected by Scd1 mutation. Our study revealed that SCD1 deficiency specifically increases CCT activity by promoting its translocation into membrane and enhances PC biosynthesis in liver.
硬脂酰辅酶A去饱和酶(SCD)是单不饱和脂肪酸合成中的限速酶。此前,我们发现Scd1基因缺失可减少肝脏甘油三酯的积累,并显著降低瘦型和肥胖型小鼠极低密度脂蛋白的合成及其分泌。在本研究中,我们发现Scd1基因缺失可显著调节肝脏甘油磷脂谱。Scd1基因敲除小鼠肝脏中磷脂酰胆碱(PC)的含量增加了40%,从头合成PC的限速酶CTP:胆碱胞苷转移酶(CCT)的活性以及胆碱磷酸转移酶的活性分别增加了64%和53%。相比之下,通过磷脂酰乙醇胺甲基化参与PC合成的磷脂酰乙醇胺N-甲基转移酶的蛋白水平在Scd1基因敲除小鼠肝脏中降低了80%。CCT的激活需要其向膜的转位。免疫印迹分析表明,与野生型小鼠相比,Scd1基因敲除小鼠肝脏中与质膜相关的CCTα是野生型小鼠的两倍,这表明Scd1突变导致CCT对膜的亲和力增加。与野生型小鼠的原代肝细胞相比,Scd1基因敲除的原代肝细胞中[(3)H]甘油掺入PC的量增加了2.5倍。此外,Scd1基因敲除小鼠肝脏中线粒体甘油-3-磷酸酰基转移酶的活性降低了42%;然而,微粒体甘油-3-磷酸酰基转移酶、二酰基甘油酰基转移酶和乙醇胺磷酸转移酶的活性不受Scd1突变的影响。我们的研究表明,SCD1缺乏通过促进其向膜的转位特异性地增加CCT活性,并增强肝脏中PC的生物合成。